A phase I trial of AB-107 topical formulation for the treatment of psoriasis
Latest Information Update: 29 Mar 2024
At a glance
- Drugs AB 107 (Primary)
- Indications Psoriasis
- Focus Adverse reactions
Most Recent Events
- 26 Feb 2019 New trial record
Latest Information Update: 29 Mar 2024